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ABSTRACT: Propargyl amines 4, where R3 is aryl, undergo 5-exo-dig cyclization reactions under relatively mild conditions
(AgNO3, DMF, 60 °C, 1 h) to give 3-amino-2,3-dihydro-2-arylmethylidenebenzofurans 5 (R
3 = aryl). In contrast, substrates
where R3 is alkyl undergo competing 6-endo-dig and 5-exo-dig cyclization processes. The hydroxymethyl substrate 4 (R3 =
CH2OH), however, was smoothly converted to its corresponding 5-exo-dig cyclization product 5, likely due to the assistance of
the primary hydroxyl group in the 5-exo-dig cyclization process by silver cation coordination. Under more enforcing conditions
(AgNO3, DMF, 100 °C, 18 h), the initially formed products 5 undergo a 1,3-allylic rearrangement to their corresponding 2-
substituted benzofuran derivatives 6. This rearrangement can also be effected by treating 5 with AgNO3 in DMF at 100 °C for 18
h or BF3·Et2O at rt. 2-(3-Butenyl)benzofurans 7 (Nu = allyl) can be prepared by treatment of 5 with BF3·Et2O and
allyltributylstannane. Furan and MeOH could also be employed as external nucleophiles in these BF3·Et2O-promoted reactions.
■ INTRODUCTION
α-Aryl-2-benzofuranmethamines have valuable medicinal chem-
istry properties. For example, compounds of the general
structure 1 have been reported to be s-1 receptor ligands,1 have
analgesic2 and Ca2+ antagonist3 properties, and applications in
the treatment of arrhythmic, histaminic, and tussive conditions
(Figure 1).4 These compounds have been prepared from the
corresponding carbinols 2 via amine substitution reactions of
the corresponding chlorides 3.4 The prerequisite carbinols 2 are
generally prepared from 2-lithiobenzofuran and an arylaldehyde
(Figure 1).4 More recently, the Petasis, boronic acid Mannich
reaction has been used to prepare a single α-aryl-2-
benzofuranmethamine, 4-(2-benzofuranylphenylmethyl)-
morpholine (1, where NR1R2 = morpholino and Ar = 2-
hydroxyphenyl), in yields varying from 235 to 95%.6 This
reaction, however, will be limited to the preparation of 2-
hydroxyaryl derivatives. We report here a new method for
preparing α-aryl (or α-alkyl)-2-benzofuranmethamines 6 via a
novel Lewis-acid-catalyzed 1,3-allylic rearrangement of 3-
amino-2,3-dihydro-2-arylmethylidenebenzofurans 5 (Scheme
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Figure 1. α-Aryl-2-benzofuranmethamines (1) and their synthetic
precursors 2 and 3.
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1). These compounds are readily obtained from propargyl
amines 4 via AgNO3-catalyzed 5-exo-dig cycloisomerization
reactions without the need to prepare reactive and sensitive
organolithium or aryl halide reagents. We also report the
isolation of novel products from unexpected 6-endo-dig
cyclization processes and the preparation of other 2-substituted
benzofurans 7 via trapping of the intermediate α-aryl (or α-
alkyl) 2-benzofuranmethyl carbocation A with other, nonamine,
nucleophiles (Scheme 1).
In 2002, Ukhin et al.7 reported the synthesis of 2-
methylidenebenzofurans 5, from the cyclizaton reactions of
propargyl amines 4, prepared from aminals 8 of salicylaldehyde
9 and propargyl alcohols 10 according to Scheme 2. Cyclization
of 4 (X = piperidino, R3 = R4 = Me) with either AgNO3 (10
mol %) in MeCN at reflux temperature for 15 min or by
treatment with KOH in MeOH at reflux temperature for 40
min gave 5 (R1/R2 = piperidino R4 = R5 = Me) in yields of 63
and 74%, respectively. Treatment of aminal 8 (X = morpholino,
R4/R5 = cyclohexyl) with the propargylic alcohol 10 (R4/R5 =
cyclohexyl) and a stoichiometric amount of CuI in MeCN at
reflux temperature for 30 min gave 5 (R1/R2 = morpholino, R4/
R5 = cyclohexyl) directly in 39% yield (Scheme 2).
These results were supported by a study by Li et al.,8 who
reported that treatment of salicylaldehyde with a cyclic amine
(2 equiv) and a propargyl alcohol (2 equiv) or an alkyne having
a remote OH (or a propargylic NHTs group in one case) in the
presence of 5 mol % of CuI with microwave heating at 130 °C
for 30 min gave 3-amino-2,3-dihydro-2-arylmethylidenebenzo-
furans 5 (R3 = CR4,R5(OH)), or their corresponding analogues,
in yields ranging from 44 to 88%. Conditions employing 5 mol
% of AgCl/MeCN/80 °C/16 h were also effective but provided
5 (R3 = CR4,R5(OH)) in slightly lower yields. Importantly, they
demonstrated that this reaction did not work with 3,3-
dimethylbut-1-yne, which suggested that the hydroxyl (or
NHTs) group on the alkyne component 10 was important to
assist cyclization via a metal coordination process in
intermediate B (Scheme 2).
In 2008, Sakai et al.9 demonstrated that these multi-
component reactions can be performed on 1-TMS-alkynes,
without the requirement of a propargylic hydroxyl group. They
employed salicylaldehyde (1.5 equiv), a cyclic or acyclic
secondary amine (1 equiv), 1-TMS-alkyne (1.5 equiv), 5 mol
% of Cu(OTf)2, and 5 mol % of CuCl with 1 molar equiv of
DMAP in MeCN at reflux temperature for 6 h. Under these
conditions, poor to excellent yields (22−99%) of 2-alkyl-3-
aminobenzofuran products 11 resulted from a base-catalyzed
isomerization of the initially formed, but never isolated, 3-
amino-2,3-dihydro-2-aryl- (or alkyl-) methylidenebenzofurans 5
(Scheme 3).
A subsequent study by Li et al.10 found similar results using
salicylaldehyde (2 equiv), a cyclic or acyclic secondary amine (1
equiv), and a terminal alkyne (1.5 equiv) using 20 mol % of
CuI, K2CO3 (1 equiv), and Bu4NBr (1 equiv) in toluene at 110
°C for 2−3 h. Of significance, to our study, was their singly
reported finding that in the absence of K2CO3 and Bu4NBr the
propargyl amine 4 (R1/R2 = morpholine, R3 = phenyl) was
obtained in 84% yield. Further, in one other example, using 1-
octyne, a separable mixture (ca. 1:1) of 5 and 11 (R1/R2 =
morpholine, R3 = hexyl) was obtained, suggesting to us that our
targeted compounds of general structure 5 might be isolatable
in better yields under less basic conditions. A related study by
Zhang and Fan11 demonstrated that these reactions to give
compounds 11 could be performed efficiently using salicy-
laldehyde (1 equiv), a cyclic or acyclic secondary amine (1.2
equiv), and a terminal alkyne (1.5 equiv), CuI (10 mol %), and
[bmim]OAc (20 mol %) in [bmim]PF6 at 80 °C for 6−9 h.
The cyclization reactions of the propargyl alcohol analogues
of the propargyl amines 4 (R3 = H or aryl but not alkyl) have
been previously studied. These reactions give the analogous 3-
hydroxy-2,3-dihydro-2-arylmethylidenebenzofurans (the 3-hy-
droxy analogues of 5) which undergo rearrangement to 2-
hydroxmethyl benzofurans or 2-alkoxybenzofurans upon
exposure to acid or an alcohol and acid, respectively.12
Scheme 1
Scheme 2
Scheme 3
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■ RESULTS AND DISCUSSION
The prerequisite propargyl amines 4, required for the synthesis
of compounds 5 and then 6, were prepared using the method
of Li10 (method A, Table 1), or a modification of this method
using AgNO3 instead of CuI (method B) or the method of
Adapa13 (method C, Table 1) from the one-pot reactions of
salicylaldehyde 9, a cyclic or acyclic secondary amine
(HNR1R2), and a terminal alkyne (HCCR3) in toluene
solution using either CuI (20 mol %), AgNO3 (20 mol %), or
Zn(OAc)2·2H2O (10 mol %) as catalysts, respectively, at 110−
120 °C (Table 1).
Method A provided the propargyl amine 4a in 63% yield
(Table 1, entry 1). However, we found that a better yield of 4a
could be obtained using AgNO3 as the catalyst rather than CuI.
Method B provided the propargyl amines 4a−4e (Table 1,
entries 2−6), all in good yields (84−92%) except for the
pyrrolidino adduct 4c (47% yield). While method C was more
efficient (97% yield) in giving the propargyl amine 4f from
heptyne when compared to method A or B (Table 1, entries 7−
9). Interestingly, method B (Table 1, entry 8) also provided a
small amount (0.7%) of the novel spirocyclic compound 12
whose structure was determined by a single-crystal X-ray
analysis (Supporting Information). A possible mechanism for
the formation of 12 is shown in Scheme 4. This mechanism
involves formation of the flavylium ion intermediate D,14
formed from cyclization of the intermediate B (Scheme 2) via a
6-endo-dig process15 (Scheme 4). Coupling of intermediates E
and F followed by an intramolecular spirocyclization process
gives the spirocyclic compound 12.
In the reactions involving salicylaldehyde 9, piperidine, and
propargyl alcohol (Table 1, entries 10 and 11), method B gave
a separable mixture of 4g and the 2-methylidenebenzofuran 5g,
while method C gave only 5g in 73% yield. These results were
consistent with those of Li8 and the assistance of the primary
hydroxyl group in the 5-exo-dig cyclization process by metal
coordination in intermediate B (Scheme 2). In contrast, the
reaction of 9, piperidine, and 4-pentyn-1-ol gave only the
propargyl amine product 4h in 98% yield (Table, 1, entry 10,
method B). Clearly, the hydroxyl group in 4h is too remote to
assist in cyclization to 5h. Method B also provided 4i in 90%
yield from the reaction of 9 with the acylic amine, dibutylamine,
and phenylacetylene (Table 1, entry 14). The amines,
dibenzylamine, diallylamine, or N-methylaniline, were not
effective (Table 1, entries 14−16).
For the cyclization reactions of 4a to 5a (Scheme 1), several
metal salt catalysts were examined (CuI, AgNO3, Au(Ph3P)Cl,
or PdCl2(Ph3P)2/CuI) in various solvents (CH2Cl2, THF,
MeCN, DMF) and at several temperatures (60−120 °C). Of
these, 20 mol % of AgNO3/DMF proved to be the most
efficient. These results are summarized in Table 2. Treatment
of 4a with 20 mol % of AgNO3 at 60 °C for 1 h gave the 2-
phenylmethylidenebenzofuran 5a in 90% yield (Table 1, entry
1). When this reaction was performed at 100 °C for 18 h, the
1,3-allylic rearrangement product 6a was produced in 60% yield
along with a small amount (5%) of 5a (Table 1, entry 2). The
former, milder conditions also worked well for the substrates
4b−d and 4g and 4i (Table 2, entries 3, 5, 7, 13, and 15),
providing the corresponding 2-methylidenebenzofurans 5b−d
and 5g and 5i in yields ranging from 65 to 85%. The more
electron-rich 4-methoxyphenyl-substituted derivative 4e, how-
ever, gave the 1,3-allylic rearrangement product 6e in 68% yield
(Table 2, entry 9). This product was also formed exclusively
under the harsher (100 °C for 18 h) reaction conditions (Table
2, entry 10). The reactions of the n-pentyl derivative 4f at 60 or
100 °C gave 5f in low yields (32 and 23%, Table 2, entries 11
and 12). These low yields were most likely due to a competing
6-endo-dig cyclization process that resulted in the formation of
many colored unidentifiable products apart from the (E)-enone
13, which was isolated in 6% yield (Scheme 5). Similarly, the
cyclization reaction of 4h resulted in mixtures from competing
6-endo-dig and 5-exo-dig processes. The major product (51%
yield) was the known spirocyclic compound 1416 formed by
intramolecular trapping of the flavylium ion intermediate D14
(Scheme 5). The 5-exo-dig products 5h (32%) and 6h (7%)
Table 1. Synthesis of Propargyl Amines 4a−i and 5g and 12
(Schemes 1 and 4)
entry NR1/R2 R3 methoda
products
(% yield)b
1 morpholino Ph A 4a (63)
2 morpholino Ph B 4a (84)
3 piperidino Ph B 4b (87)
4 pyrrolidino Ph B 4c (47)
5 morpholino 4-FC6H4 B 4d (86)
6 morpholino 4-MeOC6H4 B 4e (92)
7 morpholino n-pentyl A 4f (50)
8 morpholino n-pentyl B 4f (13), 12 (0.7)
9 morpholino n- pentyl C 4f (97)
10 piperidino CH2OH B 4g (43), 5g (44)
11 piperidino CH2OH C 4g (0), 5g (73)
12 piperidino (CH2)3CH2OH C 4h (98)
13 dibutylamino Ph C 4i (90)
14 dibenzylamino Ph B or C 4j (0)
15 diallylamino Ph B or C 4k (0)
16 N-methylanilino Ph B or C 4l (0)
aMethod A (from Li et al.):10 9 (2 equiv), HNR1R2 (1 equiv) and
HCCR3 (1.5 equiv), CuI (20 mol %), 110 °C, 24 h. Method B: 9 (2
equiv), HNR1R2 (1 equiv) and HCCR3 (1.5 equiv), AgNO3 (20
mol %), 110 °C, 24 h. Method C (from Adapa et al.):13 9 (1 equiv),
HNR1R2 (1.3 equiv) and HCCR3 (1.5 equiv), Zn(OAc)2·2H2O (10
mol %), 120 °C, 24 h. bAfter purification by column chromatography.
Scheme 4
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were also obtained (Table 2, entry 13). The hydroxymethyl
substrate 4g (R3 = CH2OH), however, was smoothly converted
to the 5-exo-dig cyclization product 5g in 84% yield (Table 2,
entry 13), for the reasons discussed above.
Heating a solution of 5a with AgNO3 (20 mol %) in DMF at
100 °C for 24 h also provided the rearranged benzofuran 6a in
68% yield. No detectable (TLC or NMR analysis) amount of
6a was formed when a DMF solution of 5a was heated at 100
°C for 24 h in the absence of AgNO3.
Table 3 provides a summary of our study on the BF3·Et2O-
catalyzed 1,3-allylic rearrangements of 5 to 6 and the
preparation of other 2-substituted benzofurans 15−17 via
trapping of the assumed ion pair intermediate A (Scheme 1)
with an external nucleophile (Scheme 6).
Treatment of a CH2Cl2 solution of 5a with BF3·Et2O (1.5
equiv) at rt for 2 h gave the rearranged benzofuran 6a in 87%
yield (Table 3, entry 1). In contrast, the rearrangement
reactions of the corresponding piperidino and pyrrolidino
derivatives, 5b and 5c, were considerably slower and required
reaction times of 18−24 h to obtain close to 50% conversions.
This resulted in lower yields of 6b and 6c, respectively, due to
reisolation of unreacted starting materials (Table 3, entries 2
and 3). Compound 6b was more readily prepared from the
cyclization of 4b with AgNO3 at 100 °C (Table 2, entry 4). The
morpholino derivative 5d, having a deactivating 4-fluorophenyl
substituent, also underwent smooth conversion to its
rearranged product 6d in 96% yield. The n-pentyl derivative
5f was found to react even more sluggishly than 5b or 5c and
provided 6f in only 22% yield along with 66% yield of
recovered unreacted starting material (Table 3, entry 4). The
dibutylamino compound 5i, however, provided the rearranged
product 6i in 87% yield (Table 3, entry 5). Clearly, the
morpholino derivatives 5a and 5d underwent BF3·Et2O-
promoted rearrangements to their corresponding benzofurans
6a,d more readily than their piperidino and pyrrolidino
analogues 5b and 5c. These results are in accord with the
relative basicities (Kb values)
17 of these amino groups, where
Table 2. Synthesis of 3-Amino-2,3-dihydro-2-
arylmethylidenebenzofurans 5 and/or α-Aryl (or α-Alkyl) 2-
Benzofuranmethamines 6 from the AgNO3-Catalyzed
Cyclization Reactions of Propargyl Amines 4 (Schemes 1
and 5)a
entry
propargyl amine 4
(NR1R2/R3)
AgNO3 (20 mol %), DMF
temp (°C)/time (h)
products (%
yield)a
1 4a (morpholino/Ph) 60/1 5a (90)
2 4a (morpholino/Ph) 100/18 5a (5), 6a
(60)
3 4b (piperidino/Ph) 60/1 5b (78)
4 4b (piperidino/Ph) 100/18 5b (17), 6b
(53)
5 4c (pyrrolidino/Ph) 60/1 5c (65)
6 4c (pyrrolidino/Ph) 100/18 5c (2), 6c
(36)
7 4d (morpholino/4F-
C6H4)
60/1 5d (81)
8 4d (morpholino/4F-
C6H4)
100/18 5d (13), 6d
(52)
9 4e (morpholino/
4MeO-C6H4)
60/1 6e (68)
10 4e (morpholino/
4MeO-C6H4)
100/18 6e (69)
11 4f (morpholino/n-
pentyl)
60/1 5f (32), 13
(6)
12 4f (morpholino/n-
pentyl)
100/18 5f (23)
13 4g (piperidino/
CH2OH)
60/1 5g (84)
14 4h (piperidino/
(CH2)3CH2OH
60/1 5h (32), 14
(51)
15 4i (dibutylamino/
Ph)
60/1 5i (85)
aAfter purification by column chromatography.
Scheme 5
Table 3. Synthesis of 6 and 13−15 from the BF3·Et2O-
Catalyzed Reactions of 5 with or without an External
Nucleophile (Schemes 1 and 6)a
entry
benzofuran 5
(NR1R2/R3)
time (h)/temp (°C)/external
nucleophile (equiv)
products (%
yield)a
1 5a (morpholino/
Ph)
2/rt/− 6a (87)
2 5b (piperidino/Ph) 18/rt/− 6b (58), 5b
(41)
3 5c (pyrrolidino/Ph) 24/rt/− 6c (43), 5c
(56)
5d (morpholino/
4F-C6H4)
2/rt/− 6d (96)
4 5f (morpholino/n-
pentyl)
6/rt/− 6f (22), 5f
(66)
5 5i (morpholino/n-
pentyl)
24/rt/− 6i (87)
6 5a (morpholino/
Ph)
2/rt/allylBF3K (3) 15a (0), 6a
(96)
7 5a (morpholino/
Ph)
2/rt/allylTMS (3) 15a (46), 6a
(53)
8 5a (morpholino/
Ph)
2/rt/allylSnBu3 (3) 15a (73), 6a
(26)
9 5a (morpholino/
Ph)
2/rt/furan (10) 16 (43), 6a
(54)
10 5a (morpholino/
Ph)
2/rt/MeOH (10) 17 (52), 6a
(48)
11 5b (piperidino/Ph) 18/rt/allylSnBu3 (3) 15a (87)
12 5d (morpholino/
4F-C6H4)
2/rt/allylSnBu3 (3) 15d (69), 6d
(30)
13 6e (morpholino/
4MeO-C6H4)
2/rt/allylSnBu3 (3) 15e (36)
14 5f (morpholino/n-
pentyl)
2/rt/allylSnBu3 (3) 15f (87)
aAfter purification by column chromatography.
Scheme 6
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the less basic morpholino group would be expected to be a
better leaving group (form a more stable BF3-coordinated
incipient amide ion in the ion pair A) and more readily form
the carbocation ion pair A (Scheme 1). However, the observed
similar reactivity of the morpholino and dibutylamino
substrates, 5a and 5i, suggests that other factors are important
in controling the rates of these reactions. Indeed, very few
examples are known for unactivated allylic amines undergoing
1,3-allylic rearrangements.18 In our cases, the driving force for
rearrangement of 5 to 6 is clearly the formation of a more stable
benzofuran product 6.
In an attempt to form the allylated derivative 15a, we treated
a CH2Cl2 solution of 5a with BF3·Et2O (1.5 equiv) and
potassium allyltrifluoroborate (3 equiv). This gave only the
rearranged product 6a (Table 3, entry 6). Allyltrimethylsilane
gave a 46% yield of 15a while allyltributylstannane gave 15a in
a much improved yield of 73%. In each case, the rearranged
benzofuran 6a was also formed (Table 3, entries 7 and 8).
Under similar reaction conditions, 15a could be prepared in
high yield from 5b and allyltributylstannane; however, the
reaction time was 18 h (Table 3, entry 8). Similarly,
compounds 5d and 5f could be converted to their
corresponding allylated derivatives, 15d and 15f, respectively
(Table 3, entries 12 and 14). The methoxy-activated derivative
6e could also be converted to its allylated derivative 15e but in
low yield (36%, Table 3, entry 13). The furan and methanol
adducts, 16 and 17, respectively, could be prepared from the
BF3·Et2O (1.5 equiv)-promoted reactions of 5a in the presence
of furan (10 equiv) and MeOH (10 equiv), respectively. These
products were separated from nearly equal amounts of 6a
(Table 3, entries 9 and 10).
In summary, the propargyl amines 4, where R3 is aryl,
undergo cyclization under relatively mild conditions (AgNO3,
DMF, 60 °C, 1 h) to give ready access to 3-amino-2,3-dihydro-
2-arylmethylidenebenzofurans 5 (R3 = aryl). These reactions
proceed through a 5-exo-dig cyclization process. Under these
nonbasic conditions, the corresponding 2-alkyl-3-aminobenzo-
furan products 11, as reported previously,10 are not observed.
In contrast, the substrates 4f and 4h, where R3 is alkyl, undergo
competing 6-endo-dig and 5-exo-dig cyclization processes as
evident of the isolation of compounds 13 and 14. The
hydroxymethyl substrate 4g (R3 = CH2OH), however, was
smoothly converted to the 5-exo-dig cyclization product 5g in
84% yield, likely due to the assistance of the primary hydroxyl
group in the 5-exo-dig cyclization process by metal coordination
in intermediate B (R3 = CH2OH) (Scheme 2). Under more
enforcing conditions (AgNO3, DMF, 100 °C, 18 h), the initially
formed 2,3-dihydro-2-substituted methylidenebenzofurans 5
undergo a 1,3-allylic rearrangement to their corresponding 2-
substituted benzofuran derivatives 6. This rearrangement can
also be effected by treating 5 with AgNO3 in DMF at 100 °C
for 18 h or BF3·Et2O (1.5 equiv) at rt. 2-(3-Butenyl)-
benzofurans 15 can be prepared by treatment of 5 with
BF3·Et2O and allyltributylstannane; however, compound 6 is
often also formed as a minor product. Furan and MeOH could
also be employed as external nucleophiles in the BF3·Et2O-
promoted reactions of 5a.
■ EXPERIMENTAL SECTION
Melting points were determined on a capillary tube melting point
apparatus and are uncorrected. All IR spectra were run as neat samples.
1H and 13C NMR spectra were obtained in CDCl3 solution using TMS
and residual CHCl3 as an internal standard (δH 0.00, δC 77.16).
1H
NMR data were listed in order of the number of protons, multiplicity
[singlet (s), broad singlet (brs), doublet (d), triplet (t), quartet (q),
quintet (quint), and multiplet (m)], coupling constants (J) in hertz,
and assignment of nuclei concerned. NMR assignments are based
upon gCOSY, HSQC, HMBC, and, sometimes, gNOESY experiments.
High-resolution ESI mass spectra were obtained on a QTOF (ESI)
mass spectrometer. Thin layer chromatography (TLC) was performed
with precoated Merck silica gel 60 PF254 aluminum sheets, and the
spots were visualized under UV light (254 and 366 nm) and further by
spraying with an acidified aqueous solution of ammonium molybdate
and cerium(IV) sulfate then heating until charred. Column
chromatography (CC) was performed with Merck silica gel 60 (40−
60 μm) and under pressure from compressed air. All air-sensitive
reactions were carried out in predried glassware apparatus under a dry
nitrogen atmosphere.
2-(1-Morpholino-3-phenylprop-2-ynyl)phenol (4a). Method
A: A mixture of CuI (762 mg, 4.0 mmol), salicylaldehyde (4.88 g, 40
mmol), phenylacetylene (3.07 g, 30 mmol), and morpholine (1.75 g,
20 mmol) in anhydrous toluene (20 mL) was heated under N2 at 110
°C for 48 h. The solvent was removed under reduced pressure, and the
crude mixture was purified using flash column chromatography
(EtOAc/petrol (1:9)) and then crystallization with EtOAc/petrol to
give product 4a (3.68 g, 63%) as colorless crystals: mp 96−98 °C; Rf =
0.34 (EtOAc/petrol (1:4)); IR (neat) νmax 3053, 2961, 2848, 2230,
1588, 1488, 1245, 1115, 1095, and 690 cm−1; 1H NMR (300 MHz) δ
10.81 (1H, brs, ArOH), 7.57−7.53 (3H, m, ArH), 7.37−7.35 (3H, m,
ArH), 7.25 (1H, t, J = 7.2 Hz, ArH), 6.89−6.86 (2H, m, ArH), 5.09
(1H, s, CHN), 3.80 (4H, brs, 2 × CH2O), 2.79 (4H, brs, 2 × CH2N);
13C NMR (75 MHz) δ 157.1 (ArCO), 132.0 (2 × ArCH), 129.9
(ArCH), 128.89 (ArCH), 128.88 (ArCH), 128.6 (ArCH), 122.4
(ArC), 120.7 (ArC), 119.6 (ArCH), 116.6 (ArCH), 90.5 (CCAr),
81.7 (CCAr), 67.0 (2 × CH2O), 60.9 (CHN) (due to line
broadening signals for (2 × CH2N) were not observed); HRESIMS
calcd for C19H20NO2 (M + H)
+ 294.1494; found, 294.1504.
Method B: A mixture of AgNO3 (679 mg, 4.0 mmol),
salicylaldehyde (4.88 g, 40 mmol), phenylacetylene (3.07 g, 30
mmol), and morpholine (1.75 g, 20 mmol) in anhydrous toluene (20
mL) was heated under N2 at 110 °C for 48 h. The solvent was
removed under reduced pressure, and the crude mixture was purified
using flash column chromatography (EtOAc/petrol (1:9)) and then
crystallization with EtOAc/petrol to give product 4a (4.903 g, 84%).
2-(3-Phenyl-1-(piperidin-1-yl)prop-2-yn-1-yl)phenol (4b). A
mixture of AgNO3 (68 mg, 0.4 mmol), salicylaldehyde (489 mg, 4.0
mmol), phenylacetylene (306 mg, 3.0 mmol), and piperidine (170 mg,
2.0 mmol) in anhydrous toluene (10 mL) was heated under N2 at 110
°C for 48 h. The solvent was removed under reduced pressure, and the
crude mixture was purified using flash column chromatography
(EtOAc/petrol (1:19)) to product 4b (511 mg, 87%) as a yellow
solid: mp 60−62 °C; IR (neat) νmax 3062, 3037, 2942, 2837, 2211,
1603, 1583, 1459, 1319, 1242, 671, and 634 cm−1; Rf = 0.24 (EtOAc/
petrol (1:19)); 1H NMR (300 Hz) δ 7.53 (3H, brs, ArH), 7.34 (3H,
brs, ArH), 7.20 (1H, t, J = 7.2 Hz, ArH), 6.82 (2H, d, J = 7.2 Hz, ArH),
5.07 (1H, s,CHN), 2.70 (4H, brs, 2 × CH2N), 1.65 (4H, brs, 2 ×
CH2), 1.49 (2H, brs, CH2);
13C NMR (75 MHz) δ 157.7 (ArCOH),
132.0 (2 × ArCH), 129.5 (ArCH), 128.7 (2 × ArCH), 128.5 (2 ×
ArCH), 122.7 (ArC), 121.4 (ArC), 119.1 (ArCH), 116.4 (ArCH), 89.9
(CCAr), 82.4 (CCAr), 61.2 (2 × CH2N), 52.9 (CH2N), 26.1
(CH2), 24.1 (2 × CH2); HRESIMS calcd for C20H22NO (M + H)
+
292.1701; found, 292.1708.
2-(3-Phenyl-1-(pyrrolidin-1-yl)prop-2-yn-1-yl)phenol (4c). A
mixture of AgNO3 (68 mg, 0.4 mmol), salicylaldehyde (489 mg, 4.0
mmol), phenylacetylene (306 mg, 3.0 mmol), and pyrrolidine (143
mg, 2.0 mmol) in anhydrous toluene (10 mL) was heated under N2 at
110 °C for 48 h. The solvent was removed under reduced pressure,
and the crude mixture was purified using flash column chromatog-
raphy (5% EtOAc/petrol (1:19)) to give the product 4c (532 mg,
47%) as a yellow viscous oil: Rf = 0.33 (EtOAc/petrol (1:5)); IR
(neat) νmax 3053, 2967, 2840, 2219, 1590, 1465, 1348, 1257, 690, and
633 cm−1; 1H NMR (300 MHz) δ 10.99 (1H, brs, ArOH), 7.55−7.50
(3H, m, ArH), 7.34−7.31 (3H, m, ArH), 7.20 (1H, dt, J = 7.2, 0.9 Hz,
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ArH), 6.87−6.81 (2H, m, ArH), 5.25 (1H, s, CHN), 2.87−2.76 (4H,
m, 2 × CH2N), 1.86−1.82 (4H, m, 2 × CH2); 13C NMR (75 MHz) δ
157.6 (ArCOH), 131.9 (2 × ArCH), 129.4 (ArCH), 128.6 (2 ×
ArCH), 128.4 (ArCH), 127.9 (ArCH), 122.6 (ArCH), 122.2 (ArC),
119.0 (ArCH), 116.3 (ArCH), 89.1 (CCAr), 83.0 (CCAr), 57.0
(CHN), 48.9 (2 × CH2N), 23.9 (2 × CH2); HRESIMS calcd for
C19H20NO (M + H)
+ 278.1545; found 278.1546.
2-(3-(4-Fluorophenyl)-1-morpholinopro-2-yn-1-yl)phenol
(4d). A mixture of AgNO3 (68 mg, 0.4 mmol), salicylaldehyde (489
mg, 4.0 mmol), 1-ethynyl-4-fluorobenzene (391 mg, 3.0 mmol), and
morpholine (174 mg, 2.0 mmol) in anhydrous toluene (5 mL) was
heated under N2 at 110 °C for 48 h. The solvent was removed under
reduced pressure, and the crude mixture was purified using flash
column chromatography (EtOAc/petrol (1:9)) and then crystalliza-
tion with EtOAc/petrol to give the product 4d (572 mg, 91.9%) as a
pale yellow solid: mp 104−106 °C; Rf = 0.33 (EtOAc/petrol (1:4));
IR (neat) νmax 3050, 2961, 2851, 2232, 1600, 1586, 1506, 1454, 1397,
1232, 1115, 1094, 660, and 635 cm−1; 1H NMR (500 MHz) δ
10.71(1H, brs, ArOH), 7.54−7.50 (3H, m, ArH), 7.23 (1H, t, J = 7.5
Hz, ArH), 7.04 (2H, t, J = 7.5 Hz, ArH), 6.88−6.86 (2H, m, ArH),
5.05 (1H, s, CHN), 3.77 (4H, brs, 2 × CH2O), 2.75 (4H, brs, 2 ×
CH2N);
13C NMR (125 MHz) δ 162.8 (d, J = 248 Hz, ArCF), 157.05
(ArCO), 133.8 (d, J = 8.6 Hz, ArCH), 129.8 (ArCH), 128.7 (ArCH),
120.5 (ArC), 119.5 (ArCH), 118.4 (d, J = 3.9 Hz, ArC), 116.6
(ArCH), 115.8 (d, J = 22 Hz, ArCH), 89.3 (CCAr), 81.0 (CCAr),
66.9 (2 × CH2O), 60.7 (CHN), 52.1 (2 × CH2N); HREIMS calcd for
C19H19FNO2 (M + H
+) 312.1400; found 312.1397.
2-(3-(4-Methoxyphenyl)-1-morpholinopro-2-yn-1-yl)phenol
(4e). A mixture of AgNO3 (68 mg, 0.4 mmol), salicylaldehyde (489
mg, 4.0 mmol), p-ethynylanisole (396 mg, 3.0 mmol), and morpholine
(174 mg, 2.0 mmol) in anhydrous toluene (5 mL) was heated under
N2 at 110 °C for 48 h. The solvent was removed under reduced
pressure, and the crude mixture was purified using flash column
chromatography (10% EtOAc/petrol (1:9)) and then crystallization
with EtOAc/petrol to give product 4e (559 mg, 86%) as a pale yellow
solid: mp 144−146 °C; Rf = 0.24 (EtOAc/petrol (1:4)); IR (neat) νmax
3058, 3034, 2937, 2845, 2208, 1603, 1508, 1467, 1248, 1112, 829, and
803 cm−1; 1H NMR (300 MHz) δ 10.87 (1H, brs, OH), 7.57 (1H, d, J
= 7.5 Hz, ArH), 7.49−7.46 (2H, m, ArH), 7.24 (1H, t, J = 7.5 Hz,
ArH), 6.90−6.85 (3H, m, ArH), 5.07 (1H, s,CHN), 3.83 (3H, s,
OCH3), 3.80 (4H, brs, 2 × CH2O), 2.78 (4H, brs, 2 × CH2N);
13C
NMR (75 MHz) δ 160.0 (ArCOCH3), 157.1 (ArCOH), 133.5 (2 ×
ArCH), 129.8 (ArCH), 129.0 (ArCH), 120.9 (ArC), 119.5 (ArCH),
116.6 (ArCH), 114.4 (ArC), 114.2 (2 × ArCH), 90.4 (CCAr), 80.2
(CCAr), 67.0 (OCH3), 60.9 (2 × CH2O), 55.5 (2 × CH2N);
HRESIMS calcd for C20H22NO3 (M + H)
+ 324.1600; found 324.1597.
2-(1-Morpholinooct-2-yn-1-yl)phenol (4f) and 4-(3-(pentan-
2-yl)spiro[chroman-2,2′-chromen]-4-yl)morpholine (12). Meth-
od A: A mixture of AgNO3 (68 mg, 0.4 mmol), salicylaldehyde (489
mg, 4.0 mmol), 1-heptyne (289 mg, 3.0 mmol), and morpholine (174
mg, 2.0 mmol) in anhydrous toluene (5 mL) was heated under N2 at
110 °C for 48 h. The solvent was removed under reduced pressure,
and the crude mixture was purified using flash column chromatog-
raphy (EtOAc/petrol (1:19)) and then crystallization with EtOAc/
petrol to give compound 4f (75 mg, 13.0%) and compound 12 (6 mg,
0.7%). Compound 4f: colorless viscous oil; Rf = 0.24 (EtOAc/petrol
(1;9)); IR (neat) νmax 3041, 2956, 2852, 2234, 1587, 1455, 1275, 1242,
1116, 1093, and 753 cm−1; 1H NMR (300 MHz) δ 10.93 (1H, brs,
OH), 7.48 (1H, dt, J = 7.5, 1.2, ArH), 7.21 (1H, ddd, J = 7.5, 1.8, 0.6
Hz, ArH), 6.88−6.81 (3H, m, ArH), 4.84 (1H, s, CHN), 3.76 (4H, brs,
2 × CH2O), 2.67 (4H, brs, 2 × CH2N), 2.34 (2H, t, J = 7.2 Hz, (C
CCH2), 1.61 (2H, quint, J = 7.2 Hz, (CCCH2CH2CH2), 1.50−1.30
(4H, m, 2 × CH2), 0.93 (3H, t, J = 6.9 Hz, CH2CH3);
13C NMR (75
MHz) δ 157.1 (ArCOH), 129.6 (ArCH), 128.9 (ArCH), 121.2 (ArC),
119.3 (ArCH), 116.4 (ArCH), 91.2 (CCCH2), 72.2 (CCCH2),
66.9 (2 × CH2O), 60.4 (CHN), 31.2 (CH2CH2CH2), 28.6 (C
CCH2CH2), 22.3 (CH2CH3), 18.8 (CCCH2), 14.1 (CH2CH3)
[signals for 2 × CH2N were not observed due to line broadening];
HRESIMS calcd for C18H26NO2 (M + H
+) 288.1964; found 288.1959.
Compound 12: colorless crystals; mp 125−127 °C; Rf = 0.48
(EtOAc/petrol (1:4)); IR (neat) νmax 3069, 3031, 2930, 2855, 1641,
1582, 1482, 1451, 1230, 1194, 1108, and 757 cm−1; 1H NMR (300
MHz) δ 7.51 (1H, d, J = 7.8 Hz, ArCH), 7.17−7.05 (3H, m, ArCH),
6.97−6.92 (2H, m, ArCH), 6.82 (1H, d, J = 9.6 Hz, CHCHAr), 6.71
(1H, d, J = 8.1 Hz, ArCH), 6.66 (1H, d, J = 8.1 Hz, ArCH), 5.88 (1H,
d, J = 9.6 Hz, CHCHAr), 4.12 (1H, d, J = 10.5 Hz, CHN), 3.71−
3.69 (4H, m, 2 × CH2O), 2.95−2.70 (4H, m, 2 × CH2N), 2.22−2.16
(1H, m, CH), 1.80−1.60 (2H, m, CH2), 1.55−1.40 (2H, m, CH2),
1.30 (2H, sext, J = 7.2 Hz, CH2CH3), 0.89 (3H, t, J = 7.2 Hz,
CH2CH3);
13C NMR (75 MHz) δ 152.2 (ArCO), 151.1 (ArCO),
129.5 (ArCH), 128.3 (ArCH), 128.2 (ArCH), 127.1 (CHCHAr),
127.0 (ArCH), 124.5 (ArC), 123.2 (CHCHAr), 121.8 (ArCH),
121.1 (ArCH), 120.1 (ArC), 117.5 (ArCH), 116.7 (ArCH), 100.8
(C(O)2), 68.2 (2 × CH2O), 61.6 (CHN), 50.2 (2 × CH2N), 44.1
(CH), 30.6 (CH2), 30.3 (CH2), 23.4 (CH2CH3), 14.2 (CH2CH3);
HRESIMS calcd for C25H30NO3 (M + H)
+ 392.2226; found 392.2231.
Method B: A mixture of CuI (381 mg, 2.0 mmol), salicylaldehyde
(2.44 g, 20 mmol), 1-heptyne (1.44 g, 15 mmol), and morpholine
(872 mg, 10 mmol) in anhydrous toluene (10 mL) was heated under
N2 at 110 °C for 48 h. The solvent was removed under reduced
pressure, and the crude mixture was purified using flash column
chromatography (5% EtOAc/petrol (1:19)) and then crystallization
with EtOAc/petrol to give compound 4f (1.44 g, 50%) as a colorless
oil.
Method C: A mixture of Zn(OAc)2.2H2O (88 mg, 0.2 mmol),
salicylaldehyde (489 mg, 4.0 mmol), 1-heptyne (577 mg, 6.0 mmol),
and morpholine (453 mg, 5.2 mmol) in anhydrous toluene (10 mL)
was heated under N2 at 120 °C for 24 h. The solvent was removed
under reduced pressure, and the crude mixture was purified using flash
column chromatography (EtOAc/petrol (1:19)) and then crystal-
lization with EtOAc/petrol to give compound 4f (1.13 g, 97%) as a
colorless oil.
2-(4-Hydroxy-1-(piperidin-1-yl)but-2-yn-1-yl)phenol (4g)
and 2-(3-(Piperidin-1-yl)benzofuran-2(3H)-ylidene)ethanol
(5g). A mixture of AgNO3 (68 mg, 0.4 mmol), salicylaldehyde (489
mg, 4.0 mmol), phenylacetylene (306 mg, 3.0 mmol), and piperidine
(170 mg, 2.0 mmol) in anhydrous toluene (10 mL) was heated under
N2 at 110 °C for 24 h. The solvent was removed under reduced
pressure, and the crude mixture was purified using flash column
chromatography (EtOAc/petrol (1:1)) to give compound 4g (211 mg,
43%) and compound 5g (216 mg, 44%).
Compound 4g: a brown viscous oil; Rf = 0.24 (EtOAc/petrol
(1:1)); IR (neat) νmax 3405, 3042, 2934, 2854, 2234, 1608, 1589, 1664,
1366, 1275, 1245, 1060, and 753 cm−1; 1H NMR (300 MHz) δ 7.56
(1H, brs, ArOH), 7.45 (1H, d, J = 7.5 Hz, ArH), 7.15 (1H, t, J = 7.5
Hz, ArH), 6.82 (2H, d, J = 7.5 Hz, ArH), 6.79 (1H, t, J = 7.5 Hz, ArH),
4.83 (1H, s, CHN), 4.12 (2H, s, CH2OH), 2.59 (4H, brs, 2 × CH2N),
1.59 (4H, brs, 2 × CH2), 1.45 (2H, brs, CH2);
13C NMR (75 MHz) δ
157.0 (ArCOH), 129.2 (ArCH), 128.2 (ArCH), 120.9 (ArC), 119.0
(ArCH), 116.1 (ArCH), 88.2 (CCCH2), 77.8 (CCCH2), 60.3
(CHN), 50.4 (CH2OH), 45.5 (2 × CH2N), 25.7 (2 × CH2), 23.f
(CH2); HRESIMS calcd for C15H20NO2 (M + H)
+ 246.1494; found
246.1506.
Compound 5g: a brown viscous oil; Rf = 0.24 (EtOAc/petrol
(1:1)); IR (neat) νmax 3332, 3051, 2934, 2807, 1699, 1595, 1463, 1322,
1229, 1086, 969, 750, and 729 cm−1; 1H NMR (300 MHz) δ 7.38 (1H,
d, J = 7.8 Hz, ArH), 7.20 (1H, dt, J = 8.1, 0.9 Hz, ArH), 6.97 (1H, dt, J
= 7.2, 0.9 Hz, ArH), 6.93 (1H, d, J = 8.1 Hz, ArH), 4.87 (1H, s, CHN),
4.46−4.41 (2H, m, CH2OH), 3.15 (1H, brs, OH), 2.60−2.35 (4H, m,
2 × CH2N), 1.55−1.51 (4H, brs, 2 × CH2), 1.40−1.38 (2H, m, CH2);
13C NMR (CDCl3, 75 MHz) δ 157.7 (OCC), 154.7 (ArCO), 129.4
(ArCH), 126.2 (ArCH), 125.5 (ArC), 121.9 (ArCH), 109.6 (ArCH),
105.2 (CCH), 67.0 (CHN), 56.9 (CH2OH), 49.4 (2 × CH2N), 26.2
(CH2), 24.4 (CH2); HRESIMS calcd for C15H20NO2 (M + H)
+
246.1494; found 246.1486.
2-(6-Hydroxy-1-(piperidin-1-yl)hex-2-yn-1-yl)phenol (4h). A
mixture of Zn(OAc)2·2H2O (88 mg, 0.4 mmol), salicylaldehyde (489
mg, 4.0 mmol), 4-pentyn-1-ol (505 mg, 6.0 mmol), and piperidine
(443 mg, 5.2 mmol) in anhydrous toluene (10 mL) was heated under
N2 at 120 °C for 24 h. The solvent was removed under reduced
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pressure, and the crude mixture was purified using flash column
chromatography (EtOAc/petrol (1:1)) to give product 4h (1.076 g,
98%) as a colorless viscous oil: Rf = 0.44 (EtOAc/petrol (1:1)); IR
(neat) νmax 3397, 3042, 2934, 2852, 2234, 1607, 1589, 1464, 1368,
1274, 1246, 1154, 1058, 981, 858, and 805 cm−1; 1H NMR (500
MHz) δ 7.44 (1H, d, J = 8.00 Hz, ArH), 7.18 (1H, t, J = 8.00 Hz,
ArH), 6.84−6.80 (2H, m, ArH), 4.82 (1H, s, CHN), 3.81 (2H, t, J =
6.0 Hz, CH2CH2OH), 2.63−2.58 (4H, m, 2 × CH2N), 2.50−2.47 (2H
m, CH2), 1.86 (2H, quint, J = 6.5 Hz, CH2), 1.64 (4H, brs, 2 × CH2),
1.50 (2H, brs, CH2);
13C NMR (125 MHz) δ 157.7 (ArCOH), 129.3
(ArCH), 128.4 (ArCH), 121.9 (ArC), 119.0 (ArCH), 116.3 (ArCH),
89.5 (CCCH2), 73.4 (CCCH2), 61.8 (CH2OH), 60.8 (CHN),
31.8 (CH2), 26.0 (2 × CH2), 24.1 (CH2), 15.5 (CH2), [signals for 2 ×
CH2N were not observed due to line broadening]; HRESIMS calcd for
C17H24NO2 (M + H)
+ 274.1807; found 274.1796.
2-(1-(Dibutylamino)-3-phenylprop-2-yn-1-yl)phenol (4i). A
mixture of Zn(OAc)2·2H2O (88 mg, 0.4 mmol), salicylaldehyde
(489 mg, 4.0 mmol), phenylacetylene (613 mg, 6.0 mmol), and
dibutylamine (672 mg, 5.2 mmol) in anhydrous toluene (10 mL) was
heated under N2 at 120 °C for 18 h. The solvent was removed under
reduced pressure, and the crude mixture was purified using flash
column chromatography (EtOAc/petrol (1:19)) to give product 4i
(1.20 g, 90%) as a yellow viscous oil: Rf = 0.20 (EtOAc/petrol (1:4));
IR (neat) νmax 3054, 2961, 2848, 2232, 1588, 1473, 1257, 1245, 1115,
1072, 689, and 636 cm−1; 1H NMR (300 MHz) δ 11.35 (1H, brs,
ArOH), 7.60 (1H, d, J = 7.5 Hz, ArH), 7.55−7.52 (2H, m, ArH),
7.34−7.32 (3H, m, ArH), 7.23 (1H, t, J = 7.5 Hz, ArH), 6.88−6.83
(4H, m, 2 × CH2N) 5.30 (1H, s,CHN), 2.72−2.52 (4H, m, 2 ×
CH2N), 1.68−1.49 (4H, m, 2 × CH2); 1.48−1.21 (4H, m, 2 × CH2),
0.90 (6H, t, J = 7.5 Hz, 2 × CH2CH3);
13C NMR (75 MHz) δ 157.4
(ArCO), 131.9 (2 × ArCH), 129.4 (ArCH), 128.6 (2 × ArCH), 128.4
(2 × ArCH), 122.7 (ArC), 122.0 (ArC), 119.1 (ArCH), 116.4 (ArCH),
89.2 (CCAr), 82.8 (CCAr), 57.1 (CHN), 51.0 (2 × CH2N), 30.0
(2 × CH2CH2CH2), 20.7 (2 × CH2CH3), 14.0 (2 × CH2CH3);
HRESIMS calcd for C23H30NO (M + H)
+ 336.2327; found 336.2343.
4-(2-Benzylidene-2,3-dihydrobenzofuran-3-yl)morpholine
(5a). A mixture of AgNO3 (240 mg, 1.41 mmol) and 4a (2.00 g, 6.82
mmol) in anhydrous DMF (30 mL) was heated under N2 at 60 °C for
1 h. The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (EtOAc/
petrol (1:4)) and then crystallization with EtOAc/petrol to give
product 5a (1.80 g, 90%) as colorless crystals: mp 104−106 °C; Rf =
0.23 (EtOAc/petrol (1:19)); IR (neat) νmax 3035, 2939, 2849, 1681,
1608, 1447, 1339, 1229, 1209, 1109, 727, and 690 cm−1; 1H NMR
(300 MHz) δ 7.70 (2H, d, J = 8.0 Hz, ArH), 7.35 (1H, d, J = 7.0 Hz,
ArH), 7.34 (2H, t, J = 7.5 Hz, ArH), 7.25 (1H, t, J = 7.5 Hz, ArH),
7.17 (1H, t, J = 7.0 Hz, ArH), 7.00 (1H, d, J = 8.0 Hz, ArH), 6.99 (1H,
d, J = 7.5 Hz, ArH), 5.85 (1H, s, CCHAr), 4.95 (1H, s, CHN),
3.75−3.65 (4H, m, 2 × CH2O), 2.80−2.66 (2H, m, CH2N), 2.60−2.50
(2H, m, CH2N);
13C NMR (75 MHz) δ 158.2 (ArC), 153.8 (C
CHAr), 135.0 (ArC), 129.7 (ArCH), 128.5 (2 × ArCH), 128.46 (2 ×
ArCH), 126.4 (ArCH), 126.2 (ArCH), 124.4 (ArC), 122.3 (ArCH),
110.3 (ArCH), 105.7 (CCHAr), 68.2 (CHN), 67.4 (2 × CH2O),
48.8 (2 × CH2N); HRESIMS calcd for C19H20NO2 (M + H)
+
294.1494; found 294.1490.
1-(2-Benzylidene-2,3-dihydrobenzofuran-3-yl)piperidine
(5b). A mixture of AgNO3 (161 mg, 0.95 mmol) and 4b (1.385 g, 4.75
mmol) in anhydrous DMF (25 mL) was heated under N2 at 60 °C for
1 h. The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (EtOAc/
petrol (1:9)) to give product 5b (1.086 g, 78%) as a pale yellow solid:
mp 78−80 °C; Rf = 0.25 (EtOAc/petrol (1:9)); IR (neat) νmax 3050,
2942, 2808, 1686, 1606, 1590, 1459, 1331, 1227, 1209, 753, and 691
cm−1; 1H NMR (300 MHz) δ 7.73 (2H, d, J = 8.0 Hz, ArH), 7.42−
7.33 (3H, m, ArH), 7.26−7.19 (2H, m, ArH), 7.04−7.01 (2H, m,
ArH), 5.85 (1H, s, CCHAr), 4.96 (1H, s, CHN), 2.72−2.63 (2H, m,
CH2N), 2.52−2.42 (2H, m, CH2N), 1.59−1.50 (4H, m, 2 × CH2),
1.43−1.34 (2H, m, CH2); 13C NMR (75 MHz) δ 158.2 (ArCO), 154.9
(OCCH), 135.4 (ArC), 129.4 (ArCH), 128.5 (2 × ArCH), 126.2 (2
× ArCH), 125.4 (ArC), 122.1 (ArCH), 110.1 (ArCH), 105.0 (C
CHAr), 68.8 (CHN), 49.8 (2 × CH2N), 26.6 (2 × CH2), 24.6 (CH2);
HRESIMS calcd for C20H22NO (M + H)
+ 292.1701; found 292.1710.
1-(2-Benzylidene-2,3-dihydrobenzofuran-3-yl)pyrrolidine
(5c). A mixture of AgNO3 (229 mg, 1.35 mmol) and 4c (1.883 g, 6.79
mmol) in anhydrous DMF (30 mL) was heated under N2 at 60 °C for
1 h. The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (EtOAc/
petrol (1:19)) to give product 5c (1.221 g, 65%) as a brown viscous
oil: Rf = 0.23 (EtOAc/petrol (1:4)); IR (neat) νmax 3053, 2965, 2811,
1686, 1611, 1594, 1461, 1347, 1228, 1210, 1069, 748, and 692 cm−1;
1H NMR (300 MHz) δ 7.72 (2H, d, J = 7.5 Hz, ArH), 7.41 (1H, d, J =
7.0 Hz, ArH), 7.35 (2H, J = 7.5 Hz, d, ArH), 7.25 (1H, t, J = 7.5 Hz,
ArH), 7.04 (1H, d, J = 7.5 Hz, ArH), 7.00 (1H, t, J = 7.0 Hz, ArH),
5.83 (1H, s, CCHAr), 5.16 (1H, s, CHN), 2.77−2.62 (4H, m, 2 ×
CH2N), 1.78−1.72 (4H, m, 2 xCH2); 13C NMR (75 MHz) δ 158.3
(CCHAr), 154.8 (ArCO), 135.2 (ArC), 129.5 (ArCH), 128.6 (2 ×
ArCH), 128.5 (2 × ArCH), 126.3 (ArCH), 126.2 (ArCH), 125.6
(ArC), 122.2 (ArCH), 110.3 (ArCH), 105.7 (CCHAr), 63.9
(CHN), 48.2 (2 × CH2N), 23.5 (2 × CH2); HRESIMS calcd for
C19H20NO (M + H)
+ 278.1545; found 278.1544.
1-(2-Benzylidene-2,3-dihydrobenzofuran-3-yl)pyrrolidine
(5c) and 1-(Benzofuran-2-yl(phenyl)methyl)pyrrolidine (6c). A
mixture of AgNO3 (35 mg, 0.21 mmol) and 4c (285 mg, 1.03 mmol)
in anhydrous DMF (5 mL) was heated under N2 at 100 °C for 18 h.
The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (5% EtOAc/
petrol) to give 5c (102 mg, 35.8%) and 6c (6 mg, 2.1%). Compound
6c: a viscous yellow oil; Rf = 0.38 (20% EtOAc/petrol); IR (neat) νmax
3052, 3029, 2965, 2874, 2786, 1584, 1492, 1452, 1251, 1134, 801, 744,
and 701 cm−1; 1H NMR (CDCl3, 300 MHz) δ 7.56 (2H, d, J = 7.50
Hz, ArH), 7.46 (2H, t, J = 7.50 Hz, ArH), 7.34−7.16 (5H, m, ArH),
6.63 (1H, s, CCH), 4.42 (1H, s, CHN), 2.52 (4H, brs, 2 × CH2N),
1.80 (4H, brs, 2 × CH2);
13C NMR (CDCl3, 75 MHz) δ 158.8 (OC
CH), 154.9 (ArCO), 140.6 (ArC), 128.5 (2 × ArCH), 128.3 (ArC),
128.3 (2 × ArCH), 127.7 (ArCH), 123.8 (ArCH), 122.7 (ArCH),
120.8 (ArCH), 111.5 (ArCH), 103.6 (OCCH), 69.4 (CHN), 53.5
(2 × CH2N), 23.5 (2 × CH2); HRESIMS calcd for C19H20NO (M +
H)+ 278.1545; found 278.1553.
4-(2-(4-Fluorobenzylidene)-2,3-dihydrobenzofuran-3-yl)-
morpholine (5d). A mixture of AgNO3 (22 mg, 0.13 mmol) and 4d
(203 mg, 0.65 mmol) in anhydrous DMF (5 mL) was heated under N2
at 60 °C for 1 h. The solvent was removed under reduced pressure,
and the crude mixture was purified using flash column chromatog-
raphy (EtOAc/petrol (15:85)) and then crystallization with EtOAc/
petrol to give product 5d (165 mg, 81%) as a pale yellow solid: mp
128−130 °C; Rf = 0.15 (EtOAc/petrol (1:4)); IR (neat) νmax 3063,
2973, 2932, 2823, 1690, 1593, 1508, 1457, 1340, 1228, 1210, 1106,
909, and 850 cm−1; 1H NMR (300 MHz) δ 7.71−7.66 (2H, m, ArH),
7.43 (1H, d, J = 7.8 Hz, ArH), 7.30 (1H, t, J = 7.8 Hz, ArH), 7.09−
7.02 (4H, m, ArH), 5.84 (1H, s,CCHAr), 4.98 (1H, s, CHN), 3.71−
3.68 (4H, m, 2 × CH2O), 2.79−2.72 (2H, m, CH2N), 2.58−2.51 (2H,
m, CH2N);
13C NMR (CDCl3, 75 MHz) δ 161.4 (d, J = 245 Hz,
ArCF), 158.2 (ArCO), 153.5 (CCHAr), 131.2 (ArC), 130.2
(ArCH), 130.1 (ArCH), 129.8 (ArCH), 126.3 (ArCH), 124.5 (ArC),
122.4 (ArCH), 115.5 (d, J = 21 Hz, ArCH), 115.2 (ArCH), 110.3
(ArCH), 104.6 (CCHAr), 68.2 (CHN), 67.5 (2 × CH2O), 48.8 (2
× CH2N); HRESIMS calcd for C19H19NO2F (M + H)
+ 312.1400;
found 312.1413.
4-(Benzofuran-2-yl(4-methoxyphenyl)methyl)morpholine
(6e). A mixture of AgNO3 (21 mg, 0.12 mmol) and 4e (203 mg, 0.63
mmol) in anhydrous DMF (5 mL) was heated under N2 at 60 °C for 1
h. The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (EtOAc/
petrol (1:9)) to give product 6e (137 mg, 68%) as a viscous yellow oil:
Rf = 0.28 (EtOAc/petrol (1:4)); IR (neat) νmax 3065, 3035, 2956,
2851, 2806, 1607, 1509, 1452, 1247, 1172, 1114, 1032, 1005, 811, and
746 cm−1; 1H NMR (300 MHz) δ 7.50−7.42 (4H, m, ArH), 7.23−
7.14 (2H, m, ArH), 6.86 (2H, d, J = 8.7 Hz, ArH), 6.63 (1H, s, C
CHAr), 4.45 (1H, s, CHN), 3.76 (3H, s, OCH3), 3.72 (4H, t, J = 4.5
Hz, 2 × CH2O), 2.52−2.38 (2H, m, 2 × CH2N); 13C NMR (CDCl3,
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75 MHz) δ 159.3 (ArCO), 157.3 (CCHAr), 155.0 (ArCO), 130.7
(ArC), 129.8 (2 × ArCH), 128.2 (ArC), 123.9 (ArCH), 122.8 (ArCH),
120.8 (ArCH), 119.0 (2 × ArCH),111.5 (ArCH), 105.0 (CCHAr),
69.2 (OCH3), 67.1 (2 × CH2O), 55.3 (CHN), 52.3 (2 × CH2N);
HRESIMS calcd for C20H22NO3 (M + H)
+ 324.1600; found 324.1612.
4-(2-Hexylidene-2,3-dihydrobenzofuran-3-yl)morpholine
(5f) and (E)-1-(2-Hydroxyphenyl)oct-1-en-3-one (13). A mixture
of AgNO3 (51 mg, 0.30 mmol) and 4f (432 mg, 1.50 mmol) in
anhydrous DMF (10 mL) was heated under N2 at 60 °C for 1 h. The
solvent was removed under reduced pressure, and the crude mixture
was purified using flash column chromatography (NH3/EtOAc/petrol
(1:2.5:44)) to give 5f (136 mg, 31.5%) and 13 (21 mg, 6.4%).
Compound 5f: Light yellow viscous oil; Rf = 0.30 (EtOAc/petrol
(1:4)); IR (neat) νmax 3048, 2956, 2924, 2853, 1604, 1596, 1460, 1378,
1232, 1114, 898, and 751 cm−1; 1H NMR (300 MHz) δ 7.36 (1H, dd,
J = 7.5, 0.6 Hz, ArH), 7.22 (1H, dt, J = 7.5, 0.9 Hz, ArH), 6.96 (1H, dt,
J = 7.5, 0.9 Hz, ArH), 6.90 (2H, d, J = 8.4 Hz, ArH), 4.87 (1H, dt, J =
7.2, 1.5 Hz, CCHCH2), 4.76 (1H, s, CHN), 3.68−3.65 (4H, m, 2 ×
CH2O), 2.68−2.59 (2H, m, CH2N), 2.49−2.42 (2H, m, CH2N), 2.28
(2H, appr q, J = 7.8 Hz, CCHCH2), 1.46−1.31 (6H, m, 3 × CH2),
0.90 (3H, t, J = 6.6 Hz, CH2CH3);
13C NMR (CDCl3, 75 MHz) δ
158.3 (ArCO), 151.9 (OCCH), 129.6 (ArCH), 126.3 (ArCH),
125.5 (ArC), 121.6 (ArCH), 109.7 (ArCH), 107.0 (CCHCH2), 67.5
(2 × CH2O), 66.5 (CHN), 48.5 (2 × CH2N), 31.7 (CH2), 29.6 (CH2),
25.3 (CHCH2), 22.7 (CH2), 14.3 (CH2CH3); HRESIMS calcd for
C18H26NO2 (M + H)
+ 288.1964; found 288.1959.
Compound 13: pale yellow solid; mp 72−74 °C; Rf = 0.25
(EtOAc/petrol (1:4)); IR (neat) νmax 3160, 2934, 2859, 1665, 1600,
1453, 1250, 1179, 975, and 745 cm−1; 1H NMR (300 MHz) δ 8.11
(1H, brs, ArOH), 7.69 (1H, d, J = 16.5 Hz, ArCHCH), 7.47 (1H,
dd, J = 8.0, 1.5 Hz, ArH), 7.24 (1H, dt, J = 8.0, 1.5 Hz, ArCH), 7.02
(1H, d, J = 16.5 Hz, ArCHCH), 6.96 (1H, d, J = 7.5 Hz, ArH), 6.89
(1H, t, J = 7.5 Hz, ArH), 2.71 (2H, t, J = 7.5 Hz, CH2CO), 1.69
(2H, quint, J = 7.5 Hz, CH2), 1.36−1.31 (2H, m, CH2CH3), 0.90 (3H,
t, J = 6.5 Hz, CH2CH3);
13C NMR (75 MHz) δ 204.1 (CO), 156.5
(ArCO), 140.2 (ArCHCH), 130.0 (ArCH), 129.5 (ArCH), 126.6
(ArCHCH), 121.8 (ArC), 120.6 (ArCH), 116.8 (ArCH), 40.3
(CH2CO), 31.7 (CH2), 24.6 (CH2), 22.6 (CH2CH3), 14.1
(CH2CH3); HRESIMS calcd for C14H19O2 (M + H)
+ 219.1385;
found 219.1392.
2-(3-(Piperidin-1-yl)benzofuran-2(3H)-ylidene)ethanol (5g).
A mixture of AgNO3 (235 mg, 1.38 mmol) and 4g (1.695 g, 6.61
mmol) in anhydrous DMF (40 mL) was heated under N2 at 60 °C for
1 h. The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (EtOAc/
petrol (1:1)) to give product 5g (1.426 g, 84%) as a viscous yellow oil.
See above for physical and spectroscopic data.
4-(3-(Piperidin-1-yl)benzofuran-2(3H)-ylidene)butan-1-ol
(5h) and 4′,5′-Dihydro-3′H-spiro[chromene-2,2′-furan] (14). A
mixture of AgNO3 (138 mg, 0.81 mmol) and 4h (1,113 mg, 4.07
mmol) in anhydrous DMF (20 mL) was heated under N2 at 60 °C for
1 h. The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (50%
EtOAc/petrol) to give 12a (393 mg, 51.3%) and 5h (356 mg, 32.0%).
Compound 14: colorless oil; Rf = 0.20 (5% EtOAc/petrol (1:19));
IR (neat) νmax 3046, 2981, 2886, 1642, 1605, 1487, 1189, 1121, 1063,
984 949, 842, and 754 cm−1; 1H NMR (300 MHz) δ 7.20−7.09 (2H,
m, ArH), 6.92−6.88 (2H, m, ArH), 6.68 (1H, d, J = 9.6 Hz, ArCH
CH), 5.72 (1H, d, J = 9.6 Hz, ArCHCH), 4.20−3.85 (2H, m,
CH2O), 2.37−2.32 (2H, m), 2.04−1.98 (2H, m); 13C NMR (75
MHz) δ 151.8 (ArCO), 129.2 (ArCH), 126.88 (ArCH), 126.85
(ArCHCH), 122.6 (ArCHCH), 121.2 (ArCH), 120.4 (ArC),
116.5 (ArCH), 105.3 (C(O)2), 68.3 (CH2O), 39.2 (CH2), 24.5 (CH2);
ESIMS m/z 189 (M + H)+. Spectroscopic data are identical to those in
the literature.16
Compound 5h: brown viscous oil; Rf = 0.27 (50% EtOAc/petrol);
IR (neat) νmax 3336, 2934, 2853, 1699, 1612, 1595, 1462, 1323, 1227,
1086, 750, and 729 cm−1; 1H NMR (500 MHz) δ 7.36 (1H, d, J = 7.5
Hz, ArH), 7.20 (1H, t, J = 8.0 Hz, ArH), 6.95 (1H, t, J = 7.5 Hz, ArH),
6.87 (1H, d, J = 8.0 Hz, ArH), 4.89 (1H, dt, J = 7.5, 1.5 Hz, CCH),
4.75 (1H, s, CHN), 3.69 (2H, t, J = 6.5 Hz, CH2OH), 2.75 (1H, brs,
OH), 2.54−2.52 (2H, m, CH2N), 2.41−2.34 (4H, m, CH2N and C
CHCH2), 1.73 (2H, quint, J = 7.0 Hz, CH2CH2CH2), 1.56−1.48 (4H,
m, 2 × CH2), 1.40−1.36 (2H, m, CH2); 13C NMR (125 MHz) δ 158.0
(ArCO), 153.3 (OCCHAr), 129.3 (ArCH), 126.3 (ArCH), 125.9
(ArC), 121.6 (ArCH), 109.5 (ArCH), 105.1 (CCHAr), 66.9
(CHN), 62.1 (CH2OH), 49.4 (2 × CH2N), 32.5 (CH2), 26.3 (2 ×
CH2), 24.5 (CH2), 21.5 (CCHCH2); HRESIMS calcd for
C17H24NO2 (M + H)
+ 274.1807; found 274.1807.
2-Benzylidene-N,N-dibutyl-2,3-dihydrobenzofuran-3-amine
(5i). A mixture of AgNO3 (109 mg, 0.64 mmol) and 4i (1.080 g, 3.22
mmol) in anhydrous DMF (20 mL) was heated under N2 at 60 °C for
1 h. The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (EtOAc/
petrol (1:49)) to give product 5i (1.086 g, 84.5%) as a viscous yellow
oil: Rf = 0.70 (EtOAc/petrol (1:4)); IR (neat) νmax 3055, 3024, 2955,
2929, 2865, 2820, 1685, 1610, 1595, 1460, 1341, 1228, 1209, 1083,
917, 747, and 693 cm−1; 1H NMR (300 MHz) δ 7.70 (2H, d, J = 7.5
Hz, ArH), 7.38−7.33 (3H, m, ArH), 7.25−7.15 (2H, m, ArH), 7.03−
7.95 (2H, m, ArH), 5.80 (1H, s,CCHAr), 5.19 (1H, s, CHN), 2.63−
2.44 (2H, m, 2 × CH2N), 1.45 (4H, quint, J = 7.5 Hz, 2 × CH2), 1.30
(4H, sext, J = 7.2 Hz, 2 × CH2CH3), 0.86 (6H, t, J = 7.2 Hz, 2 ×
CH2CH3);
13C NMR (75 MHz) δ 158.0 (ArCO), 156.2 (OC
CHAr), 135.5 (ArC), 129.2 (ArCH), 128.5 (2 × ArCH), 128.4 (2 ×
ArCH), 126.4 (ArC), 126.1 (ArCH), 125.9 (ArCH),122.1 (ArCH),
110.3 (ArCH), 104.2 (CCHAr), 64.3 (CHN), 50.9 (2 × CH2N),
31.1 (2 × CH2), 20.5 (2 × CH2CH3), 14.2 (2 × CH2CH3); HRESIMS
calcd for C23H30NO (M + H)
+ 336.2327; found 336.2332.
4-(Benzofuran-2-yl(phenyl)methyl)morpholine (6a). Method
A: A mixture of AgNO3 (12 mg, 0.07 mmol) and 5a (97 mg, 0.33
mmol) in anhydrous DMF (5 mL) was heated under N2 at 100 °C for
24 h. The solvent was removed under reduced pressure, and the crude
mixture was purified using flash column chromatography (EtOAc/
petrol (1:5)) to give 6a (66 mg, 68%) as a yellow viscous oil: Rf = 0.40
(20% EtOAc/petrol (1:4); IR (neat) νmax 3061, 3030, 2956, 2852,
2807, 1584, 1492, 1451, 1393, 1251, 1114, 870, 746, and 701 cm−1; 1H
NMR (300 MHz) δ 7.53 (2H, d, J = 7.5 Hz, ArH), 7.49 (1H, d, J = 8.0
Hz, ArH), 7.45 (1H, d, J = 8.5 Hz, ArH), 7.33 (2H, t, J = 8.0 Hz, ArH),
7.26 (1H, t, J = 7.5 Hz, ArH), 7.22 (1H, t, J = 7.0 Hz, ArH), 7.18 (1H,
t, J = 7.0 Hz, ArH), 6.65 (1H, s, CCH), 4.50 (1H, s, CHN), 3.73
(4H, t, J = 5.0 Hz, 2 × CH2O), 2.52−2.42 (4H, m, 2 × CH2N); 13C
NMR (75 MHz) δ 157.0 (CCO), 155.1 (ArCO), 138.7 (ArC),
128.7 (2 × ArCH), 128.6 (2 × ArCH), 128.2 (ArC), 127.9 (ArCH),
124.0 (ArCH), 122.8 (ArCH), 120.9 (ArCH), 111.5 (ArCH), 105.3
(CCH), 69.9 (CHN), 67.1 (2 × CH2O), 52.3 (2 × CH2N);
HRESIMS calcd for C19H20NO2 (M + H)
+ 294.1494; found 294.1501.
Method B in MeCN: To a solution of 5a (89 mg, 0.30 mmol) in
anhydrous CH3CN (5 mL) at rt was added BF3·Et2O (60 μL, 0.46
mmol) dropwise under N2, and the mixture was stirred at rt for 4 h.
The solution was treated with saturated NaHCO3 solution (10 mL)
and extracted with EtOAc (2 × 15 mL). The combined EtOAc extract
was washed with brine, dried (MgSO4), filtered, and evaporated under
reduced pressure. The crude mixture was purified using flash column
chromatography (EtOAc/petrol (1:9)) to give product 6a (86 mg,
97%).
Method B in CH2Cl2: To a solution of 5a (100 mg, 0.34 mmol) in
anhydrous CH2Cl2 (5 mL) at rt was added BF3·Et2O (63 μL, 0.51
mmol) dropwise under N2, and the mixture was stirred at rt for 2 h.
After a workup procedure similar to that described above, the crude
mixture was purified using flash column chromatography (EtOAc/
petrol (1:9)) to give 6a (87 mg, 87%).
1-(Benzofuran-2-yl(phenyl)methyl)piperidine (6b). The title
compound was prepared according to method B above from 5b (102
mg, 0.35 mmol) using CH2Cl2 (5 mL) and BF3·Et2O (65 μL, 0.53
mmol). After stirring the solution at rt for 18 h, the reaction mixture
was worked up as described above. The crude mixture was purified
using flash column chromatography (EtOAc/petrol (1:23)) to give 6b
(59 mg, 58%) and staring material (5b) (42 mg, 41%). Compound 6b
was obtained as a brown viscous oil: Rf = 0.28 (EtOAc/petrol (1:4));
IR (neat) νmax 3062, 3029, 2932, 2852, 2796, 1583, 1491, 1450, 1252,
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1160, 807, 744, and 699 cm−1; 1H NMR (300 MHz) δ 7.51−7.42 (4H,
m, ArH), 7.34−7.12 (5H, m, ArH), 6.61 (1H, s, OCCH), 4.55 (1H,
s, CHN), 2.41 (4H, brs, 2 × CH2N), 1.58 (4H, brs, 2 × CH2), 1.41
(2H, brs, CH2);
13C NMR (75 MHz) δ 157.9 (OCCH),155.0
(ArCO), 139.4 (ArC), 128.6 (2 × ArCH), 128.4 (2 × ArCH), 127.5
(ArCH), 123.7 (ArCH), 122.7 (ArCH), 120.7 (ArCH), 111.5 (ArCH),
105.0 (OCCH), 69.9 (CHN), 52.9 (2 × CH2N), 26.2 (2 × CH2),
24.6 (CH2); HRESIMS calcd for C20H22NO (M + H)
+ 292.1701;
found 292.1708.
1-(Benzofuran-2-yl(phenyl)methyl)pyrrolidine (6c). The title
compound was prepared according to method B above from 5c (100
mg, 0.36 mmol) using CH2Cl2 (5 mL) and BF3·Et2O (66 μL, 0.54
mmol). After stirring the solution at rt for 24 h, the reaction mixture
was worked up as described above. The crude mixture was purified
using flash column chromatography (EtOAc/petrol (1:23)) to give 6c
(43 mg, 43%) and recovered staring material (5c) (56 mg, 56%). The
physical and spectroscopic data for 6c are described above.
4-(Benzofuran-2-yl(4-fluorophenyl)methyl)morpholine (6d).
The title compound was prepared according to method B above from
5d (105 mg, 0.30 mmol) using CH2Cl2 (5 mL) and BF3·Et2O (55 μL,
0.45 mmol). After stirring the solution at rt for 1 h, the reaction
mixture was worked up as described above. The crude mixture was
purified using flash column chromatography (20% EtOAc/petrol
(1:4)) to give 6d (101 mg, 96%) as a pale yellow solid: mp 56−58 °C;
Rf = 0.35 (EtOAc/petrol (1:4)); IR (neat) νmax 3061, 3039, 2931,
2874, 2853, 2823, 1689, 1592, 1508, 1458, 1227, 1209, 1107, 1007,
909, 849, and 758 cm−1; 1H NMR (300 MHz) δ 7.55−7.44 (4H, m,
ArH), 7.27−7.16 (2H, m, ArH), 7.02 (2H, appr t, J = 15 Hz, ArH),
6.64 (1H, d, J = 0.9 Hz, CCH), 4.49 (1H, s, CHN), 3.73 (4H, t, J =
4.8 Hz, 2 × CH2O); 2.52−2.38 (4H, m, 2 × CH2N); 13C NMR (75
MHz) δ 162.4 (J = 245 Hz, ArCF), 156.6 (OCC), 155.1 (ArCO),
134.5 (d, J = 3.8 Hz, ArC), 130.3 (d, J = 8.0 Hz, ArCH), 128.1 (ArC),
124.2 (ArCH), 122.9 (ArCH), 120.9 (ArCH), 115.5 (d, J = 21.5 Hz,
ArCH), 111.5 (ArCH), 105.4 (CHC), 69.0 (CHN), 67.1 (2 ×
CH2O), 52.3 (2 × CH2N); HRESIMS calcd for C19H19FNO2 (M +
H)+ 312.1400; found 312.1397.
4-(1-(Benzofuran-2-yl)hexyl)morpholine (6f). The title com-
pound was prepared according to method B above from 5f (101 mg,
0.35 mmol) using CH2Cl2 (5 mL) and BF3·Et2O (65 μL, 0.53 mmol).
After stirring the solution at rt for 6 h, the reaction mixture was
worked up as described above. The crude mixture was purified using
flash column chromatography (EtOAc/petrol (1:23)) to give 6f (22
mg, 22%) and recovered staring material (5f) (67 mg, 66%).
Compound 6f was obtained as a light yellow oil; Rf = 0.28 (EtOAc/
petrol (1:4)); IR (neat) νmax 3064, 3036, 2954, 2929, 2853, 1613,
1577, 1452, 1251, 1116, 1004, and 743 cm−1; 1H NMR (300 MHz) δ
7.52 (1H, d, J = 7.5 Hz, ArH), 7.46 (1H, d, J = 7.5 Hz, ArH), 7.24−
7.20 (2H, m, ArH), 6.51 (1H, s, OCCH), 3.71−3.68 (4H, m, 2 ×
CH2O), 3.58 (1H, t, J = 6.5 Hz, CHN), 2.62−2.50 (4H, m, 2 ×
CH2N), 1.95−1.85 (2H, m, CH2), 1.49−1.22 (6H, m, 3 × CH2), 0.85
(3H, t, J = 6.5 Hz, CH2CH3);
13C NMR (75 MHz) δ 156.9 (OC
CH), 154.8 (ArCO), 128.2 (ArC), 123.8 (ArCH), 122.7 (ArCH),
120.8 (ArCH), 111.4 (ArCH), 105.2 (OCCH), 67.4 (2 × CH2O),
63.6 (CHN), 50.5 (2 × CH2N), 31.9 (CH2), 30.4 (CH2), 26.4 (CH2),
22.6 (CH2), 14.1 (CH2CH3); HRESIMS calcd for C18H26NO2 (M +
H)+ 288.1964; found 288.1967.
N-(Benzofuran-2-yl(phenyl)methyl)-N-butylbutan-1-amine
(6i). The title compound was prepared according to method B above
from 5i (107 mg, 0.32 mmol) using CH2Cl2 (5 mL) and BF3·Et2O (59
μL, 0.48 mmol). After stirring the solution at rt for 24 h, the reaction
mixture was worked up as described above. The crude mixture was
purified using flash column chromatography (EtOAc/petrol (1:49)) to
give 6i (99 mg, 87%) as a light yellow viscous oil: Rf = 0.70 (EtOAc/
petrol (1:4)); IR (neat) νmax 3062, 3030, 2956, 2928, 2865, 1600,
1579, 1452, 1377, 1251, 1165, 1071, 744, and 698 cm−1; 1H NMR
(300 MHz) δ 7.54−7.45 (4H, m, ArH), 7.343−7.18 (5H, m, ArH),
6.60 (1H, s, CCHAr), 5.12 (1H, s, CHN), 2.62−2.53 (2H, m,
CH2N), 2.49−2.40 (2H, m, CH2N), 1.52−1.41 (4H, m, 2 × CH2),
1.34−1.18 (4H, m, 2 × CH2CH3), 0.85 (6H, t, J = 7.5 Hz, 2 ×
CH2CH3);
13C NMR (75 MHz) δ 157.7 (OCCHAr) 155.0
(ArCO), 140.2 (ArC), 128.7 (2 × ArCH), 128.4 (ArCH), 128.2 (2
× ArCH), 127.3 (2 × ArCH), 123.7 (ArCH), 122.7 (ArCH), 120.8
(ArCH), 111.5 (ArCH), 105.8 (CCHAr), 63.6 (CHN), 50.5 (2 ×
CH2N), 30.0 (2 × CH2), 20.6 (2 × CH2CH3), 14.3 (2 × CH2CH3);
HRESIMS calcd for C23H30NO (M + H)
+ 336.2327; found 336.2318.
2-(1-Phenylbut-3-en-1-yl)benzofuran (15a). Method A: Using
Allyl Trimethylsilane. To a solution of 5a (103 mg, 0.35 mmol) and
allyl trimethylsilane (168 μL, 1.05 mmol) in anhydrous CH2Cl2 (5
mL) at rt was added BF3·Et2O (65 μL, 0.53 mmol) dropwise under
N2. After stirring at rt for 2 h, the reaction mixture was treated with
saturated NaHCO3 solution (10 mL) and extracted with CH2Cl2 (2 ×
15 mL). The combined CH2Cl2 extract was washed with brine, dried
(MgSO4), filtered, and evaporated under reduced pressure. The crude
reaction mixture was purified using flash column chromatography
(EtOAc/petrol (1:9)) to give 6a (55 mg, 53%) and 15a (40 mg, 46%).
Compound 15a was obtained as a colorless viscous oil: Rf = 0.50
(EtOAc/petrol (1:23)); IR (neat) νmax 3064, 3030, 1638, 1581, 1451,
1252, 916, 744, and 698 cm−1; 1H NMR (500 MHz) δ 7.48−7.46 (1H,
m, ArH), 7.42−7.38 (1H, m, ArH), 7.32−7.26 (4H, m, ArH), 7.24−
7.16 (3H, m, ArH), 6.46 (1H, s, OCCH), 5.82−5.69 (1H, m, CH
CH2), 5.11−4.96 (2H, m, CHCH2), 4.15 (1H, t, J = 7.5 Hz,
CHCH2), H4), 3.08−2.41 (2H, m, CH2); 13C NMR (125 MHz) δ
160.5 (OCCH), 154.9 (ArCO), 141.5 (ArC), 135.9 (CHCH2),
128.7 (2 × ArCH), 128.2 (2 × ArCH), 127.0 (ArCH), 123.6 (ArCH),
122.6 (ArCH), 120.6 (ArCH), 117.0 (CHCH2), 111.1 (ArCH),
103.0 (OCCH), 45.9 (CHCH2), 38.9 (CH2); HRESIMS calcd for
C18H17O (M + H)
+ 249.1279; found 249.1275.
Method B: Using Allyl Tributylstannane. To a solution of 5a (100
mg, 0.34 mmol) and allyltributylstanane (316 μL, 1.02 mmol) in
anhydrous acetonitrile (5 mL) at rt was added BF3·Et2O (62 μL, 0.51
mmol) dropwise under N2. After stirring for 2 h at rt, the reaction
mixture was treated with saturated NaHCO3 solution (10 mL) and
extracted with CH2Cl2 (2 × 15 mL). The combined CH2Cl2 extract
was washed with brine, dried (MgSO4), filtered, and evaporated under
reduced pressure. The crude reaction mixture was purified using flash
column chromatography (EtOAc/petrol (1:9)) to give 6a (26 mg,
26%) and 15a (61 mg, 73%).
Method C: From Allylation of 1-(2-Benzylidene-2,3-dihydro-
benzofuran-3-yl)piperidine (5b) with Allyltributylstannane. The
title compound was prepared according to method B above from 5b
(100 mg, 0.34 mmol) and allyltributylstannane (316 μL, 1.02 mmol)
using CH2Cl2 (5 mL) and BF3·Et2O (63 μL, 0.51 mmol). After stirring
the solution at rt for 18 h, the reaction mixture was worked up as
described above. The crude reaction mixture was purified using flash
column chromatography (5% EtOAc/petrol (1:23)) to give 15a (73
mg, 87%) as a colorless oil.
Method D: From Allylation of 1-(2-Benzylidene-2,3-dihydro-
benzofuran-3-yl)pyrrolidine (5c) with Allyltributylstannane. The
title compound was prepared according to method B above from 5c
(105 mg, 0.38 mmol) and allyltributylstannane (353 μL, 1.14 mmol)
using CH2Cl2 (5 mL) and BF3·Et2O (70 μL, 0.57 mmol). After stirring
the solution at rt for 18 h, the reaction mixture was worked up as
described above. The crude reaction mixture was purified using flash
column chromatography (5% EtOAc/petrol (1:23)) to give 15a (36
mg, 38%), 6c (4 mg, 3.8%), and recovered starting material (5c) (60
mg, 57%).
2-(1-(4-Fluorophenyl)but-3-en-1-yl)benzofuran (15d). The
title compound was prepared according to method B above from 5d
(99 mg, 0.32 mmol) and allyltributylstannane (298 μL, 0.96 mmol)
using CH2Cl2 (5 mL) and BF3·Et2O (59 μL, 0.48 mmol). After stirring
the solution at rt for 2 h, the reaction mixture was worked up as
described above. The crude reaction mixture was purified using flash
column chromatography (EtOAc/petrol (1:23)) to give 6d (30 mg,
30%) and 15d (59 mg, 69%). Compound 15d was obtained as a
colorless viscous oil: Rf = 0.50 (EtOAc/petrol (1:23)); IR (neat) νmax
3070, 2925, 1641, 1602, 1507, 1452, 1253, 1224, 1161, 917, and 744
cm−1; 1H NMR (300 MHz) δ 7.50−7.47 (1H, m, ArH), 7.41−7.38
(1H, m, ArH), 7.27−7.17 (4H, m, ArH), 7.04−6.96 (2H, m, ArH),
6.45 (1H, s, CCH), 5.80−5.68 (1H, m, CHCH2), 5.10−4.97
(2H, m, CHCH2), 4.13 (1H, t, J = 8.1 Hz, CHCH2), 3.00−2.91
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(1H, m, CHCH2), 2.75−2.67 (1H, m, CHCH2); 13C NMR (75 MHz)
δ 161.9 (d, J = 244 Hz, ArCF), 160.2 (OCCH), 154.9 (ArCO),
137.2 (d, J = 3.2 Hz, ArC), 135.6 (CH2CHCH2), 129.7 (d, J = 7.7
Hz, ArCH), 128.6 (ArC), 123.7 (ArCH), 122.7 (ArCH), 120.7
(ArCH), 117.3 (CH2CHCH2), 115.5 (d, J = 21.2 Hz, ArCH), 111.1
(CCCO), 103.0 (CHAr), 45.1 (CHCH2), 38.9 (CH2CHCH2);
HRESIMS calcd for C18H16OF (M + H)
+ 267.1185; found 267.1187.
2-(1-(4-Methoxyphenyl)but-3-en-1-yl)benzofuran (15e). The
title compound was prepared according to method B above from 6e
(80 mg, 0.25 mmol) and allyltributylstannane (233 μL, 0.75 mmol)
using CH2Cl2 (5 mL) and BF3·Et2O (47 μL, 0.38 mmol). After stirring
the solution at rt for 18 h, the reaction mixture was worked up as
described above. The crude reaction mixture was purified using flash
column chromatography (EtOAc/petrol (1:23)) to give 15e (25 mg,
36%) as a colorless viscous oil: Rf = 0.35 (EtOAc/petrol (1:23)); IR
(neat) νmax 3069, 3034, 2931, 2835, 1610, 1582, 1510, 1453, 1248,
1175, 1034, 915 803 and 745 cm−1; 1H NMR (300 MHz) δ 7.47 (1H,
d, J = 8.0 Hz, ArH), 7.39 (1H, d, J = 8.0 Hz, ArH), 7.23−7.13 (4H, m,
ArH), 6.85 (2H, d, J = 8.7 Hz, ArH), 6.43 (1H, s, OCCH), 5.82−
5.68 (1H, m, CHCH2), 5.07 (1H, d, J = 17.1 Hz), 4.98 (d, J = 10.2
Hz), 4.10 (1H, t, J = 7.8 Hz, CHCH2), H4), 3.77 (3H, s, OCH3),
3.00−2.91 (1H, m), 2.78−2.66 (1H, m); 13C NMR (75 MHz) δ 160.9
(OCCH), 158.6 (ArCO), 154.9 (ArCO), 136.0 (CHCH2), 133.6
(ArC), 129.1 (2 × ArCH), 128.7 (ArC), 123.5 (ArCH), 122.6 (ArCH),
120.6 (ArCH), 117.0 (CHCH2), 114.0 (2 × ArCH), 111.1 (ArCH),
102.7 (OCCH), 55.4 (OCH3), 45.0 (CHCH2), 39.0 (CH2);
HRESIMS calcd for C19H19O2 (M + H)
+ 279.1385; found 279.1376.
2-(Non-1-en-4-yl)benzofuran (15f). The title compound was
prepared according to method B above from 5f (101 mg, 0.35 mmol)
and allyltributylstannane (326 μL, 1.05 mmol) using CH2Cl2 (5 mL)
and BF3·Et2O (65 μL, 0.53 mmol). After stirring the solution at rt for 2
h, the reaction mixture was worked up as described above. The crude
reaction mixture was purified using flash column chromatography
(100% petrol) to give 15f (74 mg, 87.1%) as a colorless oil: Rf = 0.60
(5% EtOAc/petrol (1:23)); IR (neat) νmax 3072, 2926, 2857, 1641,
1586, 1451, 1251, 1171, 913, 798, and 742 cm−1; 1H NMR (300
MHz) δ 7.50−7.41 (2H, m, ArH), 7.23−7.17 (2H, m, ArH), 6.38 (1H,
s, CCH), 5.81−5.67 (1H, m, CHCH2), 5.06−4.95 (2H, m, CH
CH2), 2.95−2.83 (1H, m, CH(CH2)2), 2.58−2.38 (2H, m, CH2CH
CH2), 1.80−1.60 (2H, m, CH2), 1.27 (6H, brs, 3 × CH2), 0.85 (3H,
brs, CH2CH3);
13C NMR (75 MHz) δ 161.9 (OCC), 154.7
(ArCO), 136.4 (CHCH2), 128.9 (ArC), 123.1 (ArCH), 122.5
(ArCH), 120.4 (ArCH), 116.5 (CHCH2), 111.0 (ArCH), 102.3
(CHCO), 39.6 (CH(CH2)2), 38.3 (CH2CHCH2), 33.3 (CH2),
31.9 (CH2), 27.0 (CH2), 22.7 (CH2), 14.2 (CH2CH3); HRESIMS
calcd for C17H22O (M + H)
+ 243.1749; found 243.1741.
2-(Furan-2-yl(phenyl)methyl)benzofuran (16). To a solution
of 5a (101 mg, 0.34 mmol) and furan (248 μL, 3.40 mmol) in
anhydrous acetonitrile (5 mL) at rt was added BF3·Et2O (62 μL, 0.51
mmol) dropwise under N2. After stirring for 2 h at rt, the reaction
mixture was treated with saturated NaHCO3 solution (10 mL) and
extracted with CH2Cl2 (2 × 15 mL). The combined CH2Cl2 extract
was washed with brine, dried (MgSO4), filtered and evaporated under
reduced pressure. The crude reaction mixture was purified using flash
column chromatography (EtOAc/petrol (1:9)) to give 6a (54 mg,
54%) and 16 (40 mg, 43%). Compound 16 was obtained as a brown
viscous oil; Rf = 0.60 (EtOAc/petrol (1:5)); IR (neat) νmax 3062, 3030,
1583, 1499, 1452, 1165, 1009, 736, and 697 cm−1; 1H NMR (300
MHz) δ 7.56−7.18 (9H, m, ArH), 6.41 (1H, m, furanyl-H), 6.35 (1H,
brs, furanyl-H), 6.11 (1H, brs, furanyl-H), 5.59 (1H,s, CH); 13C NMR
(75 MHz) δ 157.6 (OCCH), 155.1 (ArCO), 153.8 (furanyl-C),
142.3 (OCCH), 138.9 (ArC), 128.8 (2 × ArCH), 128.6 (2 ×
ArCH), 128.5 (ArC), 127.6 (ArCH), 124.0 (ArCH), 122.8 (ArCH),
120.9 (ArCH), 111.3 (ArCH), 110.5 (furanyl-C), 108.1 (furanyl-C),
104.9 (furanyl-C), 45.6 (CH); HRESIMS calcd for C19H15O2 (M +
H)+ 275.1072; found 275.1064.
2-(Methoxy(phenyl)methyl)benzofuran (17). To a solution of
5a (100 mg, 0.34 mmol) and methanol (139 μL, 3.40 mmol) in
anhydrous acetonitrile (5 mL) at rt was added BF3·Et2O (62 μL, 0.51
mmol) dropwise under N2. The mixture was stirred at rt for 2 h and
then treated with saturated NaHCO3 solution (10 mL) and extracted
with CH2Cl2 (2 × 15 mL). The combined CH2Cl2 extract was washed
with brine, dried (MgSO4), filtered, and evaporated under reduced
pressure. The crude reaction mixture was purified using flash column
chromatography (EtOAc/petrol (1:9)) to give 6a (48 mg, 48%) and
17 (42 mg, 52%). Compound 17 was obtained as a light yellow oil: Rf
= 0.58 (EtOAc/petrol (1:4)); IR (neat) νmax 3062, 3032, 2931, 1822,
1600, 1451, 1252, 1087, 745, and 698 cm−1; 1H NMR (300 MHz) δ
7.50−7.14 (9H, m, ArH), 6.52 (1H, s, CCH), 5.39 (1H, s,
Ar(OCH3)CH), 3.45 (3H, s, OCH3);
13C NMR (75 MHz) δ 157.1
(CCO), 155.3 (ArCO), 138.6 (ArC), 128.6 (2 × ArCH), 128.4
(ArCH), 128.1 (ArC), 127.4 (2 × ArCH), 124.4 (ArCH), 122.8
(ArCH), 121.2 (ArCH), 111.5 (ArCH), 105.1 (CCH), 79.5
[(OCH3)CAr], 57.4 (OCH3); HRESIMS calcd for C16H15O2 (M +
H)+ 239.1072; found 239.1092.
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